Kiwi Wealth Investments Limited Partnership Bristol Myers Squibb CO Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $2.3 Million - $2.55 Million	-36,073 Reduced 14.13%	219,210 $14 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $381,446 - $432,646	5,805 Added 2.33%	255,283 $17.7 Billion
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $12.3 Million - $14.5 Million	179,082 Added 254.39%	249,478 $17.9 Billion
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $3.12 Million - $3.44 Million	43,021 Added 157.15%	70,396 $5.42 Million
Q1 2022 May 17, 2022	BUY	$61.48 - $73.72 $1.68 Million - $2.02 Million	27,375 New	27,375 $2 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $10.4 Million - $11.5 Million	-180,927 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $272,565 - $318,655	-4,972 Reduced 2.67%	180,927 $10.6 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $952,452 - $1.38 Million	20,527 Added 12.41%	185,899 $10.4 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $2.69 Million - $3.51 Million	54,637 Added 49.34%	165,372 $10.6 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $4.74 Million - $5.62 Million	110,735 New	110,735 $5.62 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account